Article Figures & Data
Figures
- Figure 1
- Coronary flow reserve (CFR) improvement after 4 weeks of enhanced external counterpulsation (EECP). *P<0.05 relative to control, #p<0.05 relative to baseline
- Figure 2
- Changes of endothelial nitric oxide synthase (eNOS) after 4 weeks enhanced external counterpulsation (EECP). *P<0.05 relative to control, #p<0.05 relative to baseline
- Figure 3
- Changes of endothelin-1 (ET-1) after 4 weeks enhanced external counterpulsation (EECP). *P<0.05 relative to control, #p<0.05 relative to baseline
- Figure 4
- Changes of Canadian Cardiovascular Society (CCS) angina class after 4 weeks enhanced external counterpulsation (EECP). *P<0.05 relative to control, #p<0.05 relative to baseline
Tables
- Table 1
- Evaluation of the clinicopathological profiles of control and EECP treated cohorts.
Parameters EECP group (n=41) Control group (n=42) P-value Age (years) 60.85 ± 8.44 59.52 ± 8.67 0.481 Gender (male/female) 20/21 17/25 0.447 Hypertension 25/41 25/42 0.893 Diabetes 10/41 7/42 0.383 Smoker 10/41 11/41 0.850 SBP (mmHg) baseline 135.90 ± 17.87 133.26 ± 16.43 0.485 4 weeks 137.76 ± 11.45 135.33 ± 12.81 0.415 DBP (mmHg) baseline 78.98± 12.25 82.76 ± 11.94 0.158 4 weeks 79.86 ± 12.97 80.04 ± 10.99 0.434 TC (mmol/L) baseline 4.28 ± 0.96 4.32± 1.12 0.380 4 weeks 4.31 ± 0.72 4.27 ± 0.79 0.361 TG (mmol/L) baseline 1.83 ± 1.08 2.07 ± 1.22 0.167 4 weeks 1.76 ± 0.66 1.93 ± 0.76 0.214 LDL-C (mmol/L) baseline 2.32 ± 0.75 2.36 ± 0.78 0.179 4 weeks 2.33 ± 0.81 2.31 ± 0.93 0.256 HDL-C (mmol/L) baseline 1.10 ± 0.30 0.96± 0.22 0.135 4 weeks 1.12 ± 0.26 1.04 ± 0.31 0.178 FBS (mmol/L) baseline 5.52 ± 0.79 5.88 ± 1.23 0.136 4 weeks 5.45 ± 1.67 5.67± 1.33 0.247 Body mass index baseline 25.82 ± 2.86 26.59 ± 2.68 0.213 4 weeks 25.67 ± 2.71 26.54 ± 2.30 0.315 LVD (mm) baseline 48.05 ± 3.59 48.51 ± 5.34 0.646 4 weeks 47.89 ± 4.30 48.65 ± 5.67 0.357 LAD (mm) baseline 36.49 ± 3.76 37.90 ± 5.24 0.165 4 weeks 37.01 ± 3.78 37.44 ± 5.61 0.412 LVEF (%) baseline 67.81 ±5.15 65.26 ± 6.87 0.127 4 weeks 66.35 ± 7.24 66.02± 7.30 0.348 EECP: enhanced external counterpulsation, SBP: systolic blood pressure, DBP: diastolic blood pressure, TC: cholesterol, TG: triglyceride, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, FBS: fasting blood glucose
EECP group (n=41) Control group (n=42) P-value Physical limitation baseline 34.34 ± 6.84 33.71 ± 6.71 0.674 4 weeks 42.65 ± 7.24*† 35.59 ± 7.61 0.000 Angina stability baseline 32.85 ± 6.61 33.61 ± 6.08 0.585 4 weeks 43.90 ± 6.34*† 36.35 ± 5.77† 0.000 Angina frequency baseline 37.17 ± 5.67 37.59 ± 5.99 0.741 4 weeks 47.53 ± 6.51*† 42.01 ± 5.29† 0.000 Treatment satisfaction baseline 43.95 ± 6.57 44.19 ± 7.05 0.873 4 weeks 55.43 ± 6.81*† 48.78 ± 8.38† 0.000 Disease perception baseline 29.73 ± 4.84 28.47 ± 6.42 0.319 4 weeks 43.39 ± 5.94*† 32.76 ± 6.73† 0.000
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.